INFINITY PHARMACEUTICALS, INC.·4

Dec 7, 9:11 AM ET

BLOCH LAWRENCE E 4

4 · INFINITY PHARMACEUTICALS, INC. · Filed Dec 7, 2017

Insider Transaction Report

Form 4
Period: 2017-12-06
BLOCH LAWRENCE E
EVP, CFO & CBO
Transactions
  • Purchase

    Common Stock

    2017-12-06$1.81/sh+500,000$905,000580,944 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    8,958.82
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.79 to $1.8246, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION